France #4 >>14149074
(translation via Yandex)
AstraZeneca announces that its anti-Covid treatment is ineffective
RESEARCH-The laboratory announced on Tuesday that the coronavirus treatment it is currently developing has not proven its effectiveness on people exposed to the virus. The tests will however continue.
La rédaction de LCI-Published on June 15, 2021 at 12: 25, updated on June 15, 2021 at 17: 49
New setback for AstraZeneca. After many countries have partially or totally turned away from its covid vaccine, the Anglo-Swedish pharmaceutical group announced on Tuesday that the coronavirus treatment it is currently developing has not proven its effectiveness on people exposed to the virus.
"The trial did not achieve the main goal of preventing cases of symptomatic Covid-19 after exposure" to the virus, AstraZeneca says in a statement.
A reduction in symptoms of only 33%
The antibody treatment, codenamed AZD7442, was intended to both prevent and treat the disease. It was in phase 3 of development, i.e. in large-scale clinical trials to measure its safety and effectiveness.
The 1,121 participants were adults over the age of 18 who were unvaccinated and had been exposed to an infected person in the previous eight days. Treatment only reduced the risk of developing Covid-19 with symptoms by 33%. Trials are continuing to evaluate the remedy on patients before exposure to the virus, and for those who have developed severe forms.
The significant investment of the United States
The development of this treatment is funded by the US government, which in return had concluded agreements with AstraZeneca to receive up to 700,000 doses this year. In total, the value of agreements with the United States for treatment development and doses in 2021 reaches $ 726 million.
In its statement, AstraZeneca says that discussions are underway "regarding next steps with the US government".
Covid-19: infections are on the rise again in the UK, the fault with the AstraZeneca vaccine ?
AstraZeneca vaccine: what to do with millions of unused doses ?
Covid-19: a treatment with suppositories tested by the Pasteur Institute of Lille
If hopes for the treatment developed by AstraZeneca are dashed, eyes now turn to the Pasteur Institute of Lille. It has just received the green light from the National Drug Safety Agency to test patients with suppositories for Covid-19. In October, the Institute announced that it had received a donation of five million euros from luxury giant LVMH to finance the clinical trial of a molecule that, tested in vitro, proved "particularly effective against the SARS-Cov-2 virus".
https://www.lci.fr/amp/sante/astrazeneca-annonce-que-son-traitement-anti-covid-est-inefficace-2188797.html?__twitter_impression=true